Coronavirus Disease 2019 and Management of Advanced Therapies in Parkinson's Disease; Peculiar Needs for Deep Brain Stimulation Patients?
Sign Up to like & getrecommendations! Published in 2020 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.13033
Abstract: We considered the review by Fasano and colleagues a stimulating document. The article defines a decisional algorithm on advanced therapies of Parkinson’s Diseases (PD) and addresses the clinical needs caused by the severe acute respiratory… read more here.
Keywords: intervention; disease 2019; disease; advanced therapies ... See more keywords
Device‐Assisted and Neuromodulatory Therapies for Parkinson's Disease: A Network Meta‐Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Movement Disorders"
DOI: 10.1002/mds.29160
Abstract: Device‐assisted and neuromodulatory therapies are the standard of care for Parkinson's disease (PD) with disabling motor complications. We aimed to compare and rank the currently available advanced therapies for PD on patient relevant outcomes. read more here.
Keywords: neuromodulatory therapies; assisted neuromodulatory; parkinson disease; device assisted ... See more keywords
Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson’s Disease
Sign Up to like & getrecommendations! Published in 2020 at "CNS Drugs"
DOI: 10.1007/s40263-020-00727-3
Abstract: There is escalating interest in cell-based therapies to restore lost dopamine inputs in Parkinson’s disease. This is based upon the rationale that implanting dopamine progenitors into the striatum can potentially improve dopamine-responsive motor symptoms. A… read more here.
Keywords: based therapies; cell based; parkinson disease; cell ... See more keywords
An update on advanced therapies for Parkinson's disease: From gene therapy to neuromodulation
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Surgery"
DOI: 10.3389/fsurg.2022.863921
Abstract: Advanced Parkinson's disease (PD) is characterized by increasingly debilitating impaired movements that include motor fluctuations and dyskinesias. At this stage of the disease, pharmacological management can result in unsatisfactory clinical benefits and increase the occurrence… read more here.
Keywords: update advanced; disease gene; advanced therapies; parkinson disease ... See more keywords